Atwood & Palmer Inc Neuronetics, Inc. Transaction History
Atwood & Palmer Inc
- $1.3 Billion
- Q1 2024
A detailed history of Atwood & Palmer Inc transactions in Neuronetics, Inc. stock. As of the latest transaction made, Atwood & Palmer Inc holds 100 shares of STIM stock, worth $184. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$184
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding STIM
# of Institutions
68Shares Held
18.4MCall Options Held
200Put Options Held
3.6K-
Archon Capital Management LLC Seattle, WA2.54MShares$4.67 Million4.16% of portfolio
-
Cannell Capital LLC Alta, WY2.46MShares$4.53 Million2.78% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL1.54MShares$2.83 Million1.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.3MShares$2.39 Million0.0% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY1.18MShares$2.17 Million0.04% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $49.7M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...